ResMed Unveils Research Linking CPAP Therapy to 22% Reduction in Cardiovascular Emergency Visits at SLEEP 2025

Reuters

2025/06/05

ResMed Unveils Research Linking CPAP Therapy to 22% Reduction in Cardiovascular Emergency Visits at SLEEP 2025

ResMed Inc., a leader in health technology focused on sleep and respiratory care, unveiled significant findings at SLEEP 2025, highlighting the cardiovascular benefits of CPAP therapy. Their research indicates that the use of CPAP therapy is associated with a 22% reduction in the risk of cardiovascular-related emergency room visits or hospitalizations. The studies also emphasize the positive impact of CPAP on obstructive sleep apnea symptoms and overall quality of life. Furthermore, ResMed is showcasing their expanded range of home-based testing solutions, which aim to simplify and expedite the diagnostic process for sleep disorders. The company's commitment to advancing sleep care is further underscored by their contribution to the American Academy of Sleep Medicine's 50th Anniversary Gallery, celebrating milestones in CPAP innovation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2541073372"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2541073372\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2541073372?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-05 21:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2541073372","market":"us","top_or_hot":-1,"title":"ResMed Unveils Research Linking CPAP Therapy to 22% Reduction in Cardiovascular Emergency Visits at SLEEP 2025","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      ResMed Unveils Research Linking CPAP Therapy to 22% Reduction in Cardiovascular Emergency Visits at SLEEP 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        ResMed Inc., a leader in health technology focused on sleep and respiratory care, unveiled significant findings at SLEEP 2025, highlighting the cardiovascular benefits of CPAP therapy. Their research indicates that the use of CPAP therapy is associated with a 22% reduction in the risk of cardiovascular-related emergency room visits or hospitalizations. The studies also emphasize the positive impact of CPAP on obstructive sleep apnea symptoms and overall quality of life. Furthermore, ResMed is showcasing their expanded range of home-based testing solutions, which aim to simplify and expedite the diagnostic process for sleep disorders. The company's commitment to advancing sleep care is further underscored by their contribution to the American Academy of Sleep Medicine's 50th Anniversary Gallery, celebrating milestones in CPAP innovation.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ResMed Unveils Research Linking CPAP Therapy to 22% Reduction in Cardiovascular Emergency Visits at SLEEP 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nResMed Unveils Research Linking CPAP Therapy to 22% Reduction in Cardiovascular Emergency Visits at SLEEP 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-05 21:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      ResMed Unveils Research Linking CPAP Therapy to 22% Reduction in Cardiovascular Emergency Visits at SLEEP 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        ResMed Inc., a leader in health technology focused on sleep and respiratory care, unveiled significant findings at SLEEP 2025, highlighting the cardiovascular benefits of CPAP therapy. Their research indicates that the use of CPAP therapy is associated with a 22% reduction in the risk of cardiovascular-related emergency room visits or hospitalizations. The studies also emphasize the positive impact of CPAP on obstructive sleep apnea symptoms and overall quality of life. Furthermore, ResMed is showcasing their expanded range of home-based testing solutions, which aim to simplify and expedite the diagnostic process for sleep disorders. The company's commitment to advancing sleep care is further underscored by their contribution to the American Academy of Sleep Medicine's 50th Anniversary Gallery, celebrating milestones in CPAP innovation.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0170899867.USD","symbol_name":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL88kHrd:1","article_id":"2541073372","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2541073372","pubTimestamp":1749128525,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"ResMed Inc., a leader in health technology focused on sleep and respiratory care, unveiled significant findings at SLEEP 2025, highlighting the cardiovascular benefits of CPAP therapy. Their research indicates that the use of CPAP therapy is associated with a 22% reduction in the risk of cardiovascular-related emergency room visits or hospitalizations. The studies also emphasize the positive impact of CPAP on obstructive sleep apnea symptoms and overall quality of life. Furthermore, ResMed is showcasing their expanded range of home-based testing solutions, which aim to simplify and expedite the diagnostic process for sleep disorders. The company's commitment to advancing sleep care is further underscored by their contribution to the American Academy of Sleep Medicine's 50th Anniversary Gallery, celebrating milestones in CPAP innovation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and tim","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","BK4567":"ESG概念","BK4585":"ETF&股票定投概念","LU2008162690.USD":"FIDELITY FUNDS - ASIA PACIFIC OPPORTUNITIES \"A\" (USD) ACC","BK4588":"碎股","BK4082":"医疗保健设备","BK4504":"桥水持仓","BK4548":"巴美列捷福持仓","RMD":"瑞思迈","LU2177674079.SGD":"Fidelity Asia Pacific Opportunities A-ACC-SGD (hedged)"},"translate_title":"ResMed公布了一项研究，将CPAP治疗与睡眠2025心血管急诊减少22%联系起来","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RMD":0.9},"content_text":"ResMed Unveils Research Linking CPAP Therapy to 22% Reduction in Cardiovascular Emergency Visits at SLEEP 2025\n    \n\n        ResMed Inc., a leader in health technology focused on sleep and respiratory care, unveiled significant findings at SLEEP 2025, highlighting the cardiovascular benefits of CPAP therapy. Their research indicates that the use of CPAP therapy is associated with a 22% reduction in the risk of cardiovascular-related emergency room visits or hospitalizations. The studies also emphasize the positive impact of CPAP on obstructive sleep apnea symptoms and overall quality of life. Furthermore, ResMed is showcasing their expanded range of home-based testing solutions, which aim to simplify and expedite the diagnostic process for sleep disorders. The company's commitment to advancing sleep care is further underscored by their contribution to the American Academy of Sleep Medicine's 50th Anniversary Gallery, celebrating milestones in CPAP innovation.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on June 05, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,merge","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}